{ "items": [ "\n\n
\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n22 January 2024
\n \n \n \nResearchers from the Medical Research Council Brain Network Dynamics Unit at the University of Oxford and the Nuffield Department of Clinical Neurosciences have identified a novel mechanism by which the brain produces powerful lasting memories that drive ill-advised actions.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n19 January 2024
\n \n \n \nThe DETECT study, led by Nuffield Department of Women's and Reproductive Health Professors Christian Becker and Krina Zondervan explores the potential of visualizing endometriosis, including hard-to-detect superficial peritoneal disease, using Serac's innovative imaging agent.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 January 2024
\n \n \n \nA recent study led by the Centre for Human Genetics at the Nuffield Department of Medicine has revealed that areas of the human genome that are routinely overlooked in clinical tests may be the cause of some rare diseases.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n17 January 2024
\n \n \n \nThe Oxford Experimental Medicine Clinical Research Facility (EMCRF) at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) has received its first volunteers as part of the LEGACY03 trial to improve vaccine design for different age groups.
\n \n\n \n \n16 January 2024
\n \n \n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n16 January 2024
\n \n \n \nThe Jenner Institute is conducting a new study, using BCG, the current licensed vaccine against tuberculosis. In this study, they will give BCG a second time to people who have already had BCG once before, and will compare whether giving it by inhalation is better at protecting people against tuberculosis than giving it into the skin
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n15 January 2024
\n \n \n \nResearch led by scientists at the Universities of Oxford, Cambridge, Copenhagen, Bristol and California (Berkeley) reveals the evolutionary origins of multiple sclerosis (MS). This new insight into the genetic architecture of this disease changes scientists\u2019 view of its causes and has implications for its treatment, as well as paving the way for further investigations into other diseases.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n12 January 2024
\n \n \n \nThe latest set of data presented by the Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries (MBRRACE-UK) Collaboration investigation into maternal deaths in the UK shows that the mortality rate for women who died during or soon after pregnancy has increased to levels not seen since 2003-05.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n12 January 2024
\n \n \n \nFirst clinical trial participants received doses of the ChAdOx1 NipahB vaccine over the last week at University of Oxford. UK trial is first step to developing a vaccine against Nipah virus \u2013 a devastating disease mostly found in South-East Asia \u2013 that can be fatal in up to 75% of cases. The milestone clinical trial comes as the global health community marks the 25th anniversary of the first Nipah virus outbreaks. There are still no approved vaccines or treatments for the disease.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n12 January 2024
\n \n \n \nA recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n11 January 2024
\n \n \n \nResearch led by scientists at the Universities of Oxford, Cambridge, Copenhagen, Bristol and California (Berkeley) reveals the evolutionary origins of multiple sclerosis (MS). This new insight into the genetic architecture of this disease changes scientists\u2019 view of its causes and has implications for its treatment, as well as paving the way for further investigations into other diseases.
\n \n\n \n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n10 January 2024
\n \n \n \nSir Stewart Cole, KCMG, FRS has joined the Ineos Oxford Institute for antimicrobial research (IOI) as Executive Chair. The IOI is a world-leading centre of research, training, and education in the field of antimicrobial resistance (AMR) based at the University of Oxford. It was established thanks to an unprecedented \u00a3100 million gift from INEOS, one of the world\u2019s largest chemical companies.
\n \n\n \n \n9 January 2024
\n \n \n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Innovation\n \n \n\n \n\n\n
\n \n\n \n8 January 2024
\n \n \n \nPlans for Warneford Park have taken a step forward as partners in the project signed a Conditional Option Agreement (COA) and Memorandum of Understanding (MOU), agreeing how they will work together going forward.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 January 2024
\n \n \n \nResearchers from the MRC Brain Network Dynamics Unit and Oxford University\u2019s Department of Computer Science have set out a new principle to explain how the brain adjusts connections between neurons during learning. This new insight may guide further research on learning in brain networks and may inspire faster and more robust learning algorithms in artificial intelligence.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 January 2024
\n \n \n \nSelective mutism is an anxiety disorder characterised by a consistent pattern of silence in specific social situations where speech is expected (for example, at school or work) while the person is able to speak comfortably in other situations.
\n \n\n \n \n\n \n\n \n \n \n \n Awards and Appointments\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n2 January 2024
\n \n \n \nMembers of the Medical Sciences Division have been recognised in the New Year's Honours list for 2024
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n19 December 2023
\n \n \n \nA ground-breaking study, published in Nature Human Behaviour, reveals a significant association between 74 early-life diseases and the likelihood of remaining childless throughout one's life, with 33 of these diseases prevalent in both women and men.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n15 December 2023
\n \n \n \nA new study led by the the Departments of Biology and Biochemistry at the University of Oxford, has demonstrated that diverse communities of resident bacteria can protect the human gut from disease-causing microorganisms. The researchers found that protective communities block the growth of harmful pathogens by consuming nutrients that the pathogen needs. The findings, published today in the journal Science, could help to develop new strategies to optimise gut health.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n15 December 2023
\n \n \n \nResearchers at the MRC Weatherall Institute of Molecular Medicine's Laboratory of Gene Regulation, led by Professor Doug Higgs and Dr Mira Kassouf have published a study in the journal Cell, in which they reveal another piece of the puzzle of how the code in our DNA is read. In this study, the authors introduce the concept of \u201cfacilitators\u201d, a newly identified type of non-coding DNA that can help to drive gene expression.
\n \n\n \n \n